Table 3.
Coverage indicators in each age group | year | Linear slope | r2 linear adjustment | |||
---|---|---|---|---|---|---|
2003 | 2004 | 2005 | 2006 | |||
Children | n = 15,289 | n = 20,762 | n = 23,177 | n = 22,365 | ||
% | % | % | % | % | % | |
Delivery of PREVENIMSS booklets | 32.1 | 62.7 | 77.2 | 90.7 | 19.0 | 95.5 |
Weight measurement | 72.2 | 73.5 | 79.0 | 84.4 | ||
Height measurement | 56.6 | 70.3 | 76.0 | 81.7 | ||
Iron supplementation in children < 1 year old | 17.8 | 46.0 | 47.7 | 65.5 | ||
Completed scheme of vaccination by age | 91.4 | 91.0 | 91.4 | 90.3 | -0.3 | 52.1 |
Fluoride application | 40.5 | 42.0 | 43.2 | 58.1 | 5.4 | 72.7 |
Hypothyroidism screening | 97.1 | 96.7 | 98.5 | 98.0 | 0.4 | 49.9 |
Screening for congenital adrenal hyperplasia, phenylketonuria and biotinidase deficiency | -- | - | 60.3 | 81.6 | 21.3 | 100.0 |
Visual acuity screening | 12.5 | 22.5 | 32.1 | 47.5 | 11.5 | 98.6 |
Adolescents | n = 13,356 | n = 20,259 | n = 21,474 | n = 20,701 | Linear slope | r2 linear adjustment |
% | % | % | % | % | % | |
Delivery of PREVENIMSS booklets | 25.9 | 54.6 | 68.9 | 84.3 | 19.0 | 97.0 |
Weight measurement | 36.3 | 57.7 | 64.1 | 73.2 | 11.7 | 92.8 |
Height measurement | 33.8 | 55.3 | 61.6 | 71.1 | 11.8 | 93.0 |
Measles-rubella vaccine | 52.4 | 55.6 | 58.8 | 71.4 | 6.0 | 87.2 |
Tetanus toxoid and diphtheria vaccine | 68.0 | 65.8 | 63.7 | 80.0 | 3.4 | 36.0 |
Hepatitis B vaccine | 9.3 | 17.7 | 26.1 | 46.2 | 11.9 | 94.5 |
Use of condom in last intercourse | 17.9 | 30.4 | 42.2 | 59.9 | 13.8 | 99.1 |
visual acuity screening | 2.1 | 30.1 | 51.5 | 61.2 | 19.9 | 95.9 |